Combining Low-Dose Post-Transplant Cyclophosphamide(PTCY) with Anti-Thymocyte Globulin( ATG) for Prophylaxis of Graft-Versus-Host Disease in Alternative-Donor Hematopoietic Stem Cell Transplantation for β-Thalassemia Major

被引：0
|
作者：
Lu, Jingyuan [1 ]
Zhuang, Yanhong [1 ]
Hong, Xiuli [1 ]
Chen, Jie [1 ]
Chen, Yanxin [1 ]
Jiang, Erlie [2 ,3 ]
Lu, Quanyi [1 ]
机构：
[1] Xiamen Univ, Zhongshan Hosp, Dept Hemotol, Xiamen, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186196
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Outcomes with low dose anti-thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation
    Chalchal, Hafsah
    Dhir, Vinita
    Masurekar, Ashish
    Atkins, Harold
    Bredeson, Christopher
    Kennah, Michael
    Kekre, Natasha
    Allan, David
    Nampoothiri, Ram Vasudevan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (04) : 543 - 549
  • [32] Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia
    Barkhordar, Maryam
    Kasaeian, Amir
    Janbabai, Ghasem
    Kamranzadeh Fumani, Hossein
    Tavakoli, Sahar
    Rashidi, Amir Abbas
    Mousavi, Seied Asadollah
    Ghavamzadeh, Ardeshir
    Vaezi, Mohammad
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
    Penack, Olaf
    Abouqateb, Mouad
    Peczynski, Christophe
    Boreland, William
    Gulbas, Zafer
    Gedde-Dahl, Tobias
    Castilla-Llorente, Cristina
    Kroeger, Nicolaus
    Eder, Mathias
    Rambaldi, Alessandro
    Bonifazi, Francesca
    Blau, Igor Wolfgang
    Stelljes, Matthias
    Dreger, Peter
    Moiseev, Ivan
    Schoemans, Helene
    Koenecke, Christian
    Peric, Zinaida
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [34] Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) Effectively Reduces the Severe (Grade III-IV) Acute Graft-Versus-Host Disease (GVHD) When Compared to ATG Alone in Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplants
    Deotare, Uday
    Loach, David
    Michelis, Frank
    Kim, Dennis
    Thyagu, Santhosh
    Lipton, Jeffrey H.
    Messner, Hans
    Viswabandya, Auro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S315 - S315
  • [35] PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
    Olaf Penack
    Mouad Abouqateb
    Christophe Peczynski
    William Boreland
    Zafer Gülbas
    Tobias Gedde-Dahl
    Cristina Castilla-Llorente
    Nicolaus Kröger
    Mathias Eder
    Alessandro Rambaldi
    Francesca Bonifazi
    Igor Wolfgang Blau
    Matthias Stelljes
    Peter Dreger
    Ivan Moiseev
    Hélène Schoemans
    Christian Koenecke
    Zinaida Peric
    Blood Cancer Journal, 14
  • [36] No indication of increased infection rates using low-dose alemtuzumab instead of anti-thymocyte globulin as graft-versus-host disease prophylaxis before allogeneic stem cell transplantation
    Neumann, Thomas
    Schneidewind, Laila
    Thiele, Thomas
    Pink, Daniel
    Schulze, Meike
    Schmidt, Christian
    Krueger, William
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (01)
  • [37] Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis in Alternative Donor Stem Cell Transplantation: Immune Reconstitution and Infection Risk
    Nagler, Arnon
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 883 - 884
  • [38] Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis
    Maria Queralt Salas
    Arjun Datt Law
    Wilson Lam
    Zeyad Al-Shaibani
    David Loach
    Dennis Dong Hwan Kim
    Fotios V. Michelis
    Santhosh Thyagu
    Rajat Kumar
    Jeffrey Howard Lipton
    Jonas Mattsson
    Auro Viswabandya
    Clinical Hematology International, 2019, 1 (2) : 105 - 113
  • [39] Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) Effectively Reduces the Severe (Grade III-IV) Acute Graft-Versus-Host Disease (GVHD) When Compared to ATG Alone in Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplants
    Deotare, Uday
    Loach, David
    Michelis, Fotios V.
    Kim, Dennis D.
    Thyagu, Santhosh
    Lipton, Jeffrey H.
    Messner, Hans A.
    Viswabandya, Auro
    BLOOD, 2016, 128 (22)
  • [40] Risk Factors for Graft-Versus-Host Disease (GVHD) in Haploidentical Hematopoietic Cell Transplantation (HCT) Using Post-Transplant Cyclophosphamide (PTCy)
    Rashidi, Armin
    Hamilton, Betty K.
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Alousi, Amin M.
    Jagasia, Madan
    Pidala, Joseph A.
    Arora, Mukta
    Im, Annie P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345